Recently Released Market Study: Hemophilia B - Pipeline Review, H2 2012
Global Markets Direct's, 'Hemophilia B - Pipeline Review, H2 2012', provides an overview of the Hemophilia B therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia B, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hemophilia B. 'Hemophilia B - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor...
View full press release